TARS

TARSUS PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.25

EPS Forecast

$155.4

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.25

Revenue Forecast:

$155.4

EPS Surprise Forecast:

$0.017

Revenue Surprise Forecast:

$5

Post-release price volatility - High

Post-release Overnight Move:

±8.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

78%

Probability of beating both EPS & revs consensus:

50%

Probability of missing both EPS & revs consensus:

14%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.21

Earnings volatility

EPS standard deviation:

$0.28

Revenue standard deviation:

$13

As % of share price:

0.42% MEDIUM

As % of market cap:

0.46% LOW

Confidence intervals and percentiles

EPS 95th %ile:

$0.11

Revenue 95th %ile:

$172

EPS 75th %ile:

-$0.16

Revenue 75th %ile:

$160

EPS 25th %ile:

-$0.33

Revenue 25th %ile:

$152

EPS 5th %ile:

-$0.56

Revenue 5th %ile:

$141

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

41% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

37% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$28

Bid-ask per Share:

$0.19